Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-003277
Filing Date
2015-02-24
Accepted
2015-02-24 18:11:16
Documents
1
Period of Report
2015-02-21

Document Format Files

Seq Description Document Type Size
1 rrd422822.html 4  
1 rrd422822.xml 4 10397
  Complete submission text file 0001181431-15-003277.txt   11949
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG, ILLINOIS 60195 IL 60195
Business Address
KUNG FRANK (Reporting) CIK: 0001227255 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 15645205

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations